IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 05774873 Brief Summary The primary objective of this study to evaluate…
Read more arrow_forwardNCT 05987332 Brief Summary This is a Phase 2/3, multi-arm, multi-stage,…
Read more arrow_forwardNCT 05365659 Brief Summary This first-in-human study will evaluate the recommended dose…
Read more arrow_forwardNCT 06112314 Brief Summary This is a phase 3, randomized, controlled study…
Read more arrow_forwardNCT 03959085 Brief Summary This phase III trial studies whether inotuzumab ozogamicin…
Read more arrow_forwardACTRN 12624000532505 Brief Summary Ewing Sarcoma is a cancer of bone or…
Read more arrow_forwardACTRN 12623000657628 Brief Summary This study aims to find out if adding…
Read more arrow_forwardACTRN 12621000955819 Brief Summary The aim of this study is to investigate…
Read more arrow_forwardNCT 04643002 Brief Summary The purpose of this umbrella study is to…
Read more arrow_forwardNCT 06465953 Brief Summary This study will enroll participants with myelodysplastic syndromes…
Read more arrow_forwardNCT 06127407 Brief Summary Study CL3-95031-007 (CHONQUER) is a Phase 3, international, multicenter, double-blind,…
Read more arrow_forwardNCT 06501625 Brief Summary The objective of this study is to investigate…
Read more arrow_forward